(Q37638155)

21 August 2017

1 reference

title

Natriuretic peptides in heart failure: should therapy be guided by BNP levels? (English)

1 reference

21 August 2017

0 references

2

Eugene Braunwald

1 reference

21 August 2017

1

Michelle O'Donoghue

1 reference

21 August 2017

language of work or name

English

0 references

publication date

24 November 2009

1 reference

Nature Reviews Cardiology

21 August 2017

published in

1 reference

21 August 2017

volume

7

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

13-20

1 reference

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Deconvolution analysis of cardiac natriuretic peptides during acute volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

ACC/AHA Clinical Performance Measures for Adults With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Influence of hospital length of stay for heart failure on quality of care.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Use of aldosterone antagonists in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

THE HEART AS AN ENDOCRINE ORGAN

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Evidence of the atrial location of receptors influencing urine flow

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

SPECIFIC GRANULES IN ATRIAL MUSCLE CELLS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

A new natriuretic peptide in porcine brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Evidence for functional heterogeneity of circulating B-type natriuretic peptide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Using the single-compartment ratio model to calculate half-life, NT-proBNP as an example

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Plasma brain natriuretic peptide concentration: impact of age and gender

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Impact of age and sex on plasma natriuretic peptide levels in healthy adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Impact of obesity on plasma natriuretic peptide levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Letter by Tang et al regarding article, "BIPHASIC trial: a randomized comparison of fixed lower versus escalating higher energy levels for defibrillation in out-of-hospital cardiac arrest".

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Cardiac fibrosis in mice lacking brain natriuretic peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

The effect of cardiac resynchronization on morbidity and mortality in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.197

National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19935742

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19935742

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2009.197

1 reference

21 August 2017

1 reference